|
|
Topics |
Replies |
Views |
Last Post |
|
|
Argentina: ANMAT - new regulatory update
by GCP HelpDesk on 2010-05-01 09:40:32 |
3 |
1136951 |
by william
on 2012-08-31 15:44:05
|
|
|
|
EFGCP–EUCROF Joint Workshop Final Report
by GCP HelpDesk on 2010-08-20 20:12:20 |
0 |
38863 |
by GCP HelpDesk
on 2010-08-20 20:12:20
|
|
|
|
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification
by GCP HelpDesk on 2010-06-13 18:11:41 |
0 |
34562 |
by GCP HelpDesk
on 2010-06-13 18:11:41
|
|
|
|
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)
by GCP HelpDesk on 2010-06-13 18:07:59 |
0 |
33742 |
by GCP HelpDesk
on 2010-06-13 18:07:59
|
|
|
|
NIH's Financial Conflict of Interest (FCOI) Proposed Rule
by GCP HelpDesk on 2010-05-27 19:42:00 |
0 |
8669 |
by GCP HelpDesk
on 2010-05-27 19:42:00
|
|
|
|
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population
by GCP HelpDesk on 2010-05-13 19:39:54 |
0 |
8073 |
by GCP HelpDesk
on 2010-05-13 22:55:29
|
|
|
|
EFGCP:Procedure for the Ethical Review of Protocols in Turkey
by GCP HelpDesk on 2010-05-01 06:35:05 |
0 |
3249 |
by GCP HelpDesk
on 2010-05-01 06:35:05
|
|
|
|
Major developments in EU Clinical Trial Guidances
by GCP HelpDesk on 2010-04-21 03:10:55 |
0 |
6957 |
by GCP HelpDesk
on 2010-04-21 03:13:23
|
|
|
|
Deming's 14 Principles-Aricle from BARQA
by Leon on 2010-04-19 06:32:54 |
0 |
3222 |
by Leon
on 2010-04-19 07:04:59
|
|
|
|
CONSORT III (2010)
by GCP HelpDesk on 2010-03-29 20:53:28 |
0 |
7296 |
by GCP HelpDesk
on 2010-03-29 20:53:28
|
|
|
|
US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function
by GCP HelpDesk on 2010-03-20 20:25:16 |
0 |
6836 |
by GCP HelpDesk
on 2010-03-20 20:25:16
|
|
|
|
US-FDA issues First Draft Guidance on Noninferiority Trials
by GCP HelpDesk on 2010-03-04 22:07:46 |
0 |
7086 |
by GCP HelpDesk
on 2010-03-04 22:07:46
|
|
|
|
US FDA new rule on reporting information regarding falsification of data
by GCP HelpDesk on 2010-02-26 04:47:33 |
0 |
7313 |
by GCP HelpDesk
on 2010-02-26 04:47:33
|
|
|
|
US-FDA Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
by GCP HelpDesk on 2010-02-06 20:12:14 |
0 |
6658 |
by GCP HelpDesk
on 2010-02-06 20:12:14
|
|
|
|
UK-MHRA's Response to the Review of the Clinical Trials Directive
by GCP HelpDesk on 2010-01-27 19:19:01 |
0 |
6082 |
by GCP HelpDesk
on 2010-01-27 19:19:01
|
|
|
|
US-FDA revised ICH Guidance:M3(R2) Nonclinical Safety Studies for Conduct of CT
by GCP HelpDesk on 2010-01-22 18:07:03 |
0 |
6345 |
by GCP HelpDesk
on 2010-01-22 18:07:03
|
|
|
|
US-FDA Draft Guidance Recommends DSMBs, CECs for Heart Valve Studies
by GCP HelpDesk on 2010-01-21 19:22:51 |
0 |
6085 |
by GCP HelpDesk
on 2010-01-21 19:22:51
|
|
|
 |
FDA Issues Draft Guidance on IRB Continuing Review
by GCP HelpDesk on 2010-01-14 04:07:29 |
0 |
5773 |
by GCP HelpDesk
on 2010-01-14 04:07:29
|
|
|
|
FDA's proposed rule on Post-marketing Safety Reporting for Combination Prodcuts
by GCP HelpDesk on 2010-01-12 20:15:13 |
0 |
5877 |
by GCP HelpDesk
on 2010-01-12 20:15:13
|
|
|
|
EMEA Guidelines on Cystic Fibrosis Drug Development
by GCP HelpDesk on 2010-01-05 17:14:16 |
0 |
5933 |
by GCP HelpDesk
on 2010-01-05 17:14:16
|
